Disclosure Of Entity's Operating Segments [Text Block]

Pharming Group N.V. - Filing #1883078

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of entity's operating segments [text block]	—	—	—	Segment information	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	—	—	205,622,000 USD	—	—	—	—	—	—	198,871,000 USD	—
Tax expense (income)	—	—	—	1,313,000 USD	—	—	—	—	—	—	7,082,000 USD	—
Profit (loss) before tax	—	—	—	14,987,000 USD	—	—	—	—	—	—	23,078,000 USD	—
Profit (loss)	—	— USD	— USD	13,674,000 USD	— USD	13,674,000 USD	—	— USD	— USD	— USD	15,996,000 USD	15,996,000 USD
Assets	425,797,000 USD	—	—	—	—	—	397,315,000 USD	—	—	—	—	—
Investments accounted for using equity method	2,501,000 USD	—	—	—	—	—	7,201,000 USD	—	—	—	—	—
Cash flows from (used in) operating activities	—	—	—	22,458,000 USD	—	—	—	—	—	—	37,842,000 USD	—
Cash flows from (used in) investing activities	—	—	—	5,323,000 USD	—	—	—	—	—	—	21,305,000 USD	—
Cash flows from (used in) financing activities	—	—	—	4,982,000 USD	—	—	—	—	—	—	27,947,000 USD	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]